A double-blind, placebo-controlled, crossover trial of soy phytoestrogens in patients with compensated hypothyroidism
Not Applicable
Completed
- Conditions
- Compensated hypothyroidismNutritional, Metabolic, EndocrineHypothyroidism
- Registration Number
- ISRCTN55827330
- Lead Sponsor
- Hull and East Yorkshire Hospitals Trust (UK)
- Brief Summary
2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21325465 2019 follow-up analysis in: https://www.ncbi.nlm.nih.gov/pubmed/31031706
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with newly diagnosed compensated hypothyroidism (thyroid stimulating hormone [TSH] >4.7 and normal T4)
Exclusion Criteria
1. Patients on thyroxine or drugs that interfere with thyroid function
2. Patients who have had antibiotics within 3 months of starting the trial
3. Patients not wishing to allow disclosure to their general practitioners (GPs)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method